Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.210
+0.005 (0.41%)
Jul 27, 2026, 4:00 PM EDT - Market closed
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $45.55 million as of July 28, 2026. Its market cap has decreased by -49.85% in one year.
Market Cap
45.55M
Enterprise Value
-55.42M
1-Year Change
-49.85%
Ranking
Category
Stock Price
$1.21
ChartMarket Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $45.55M, a decrease of -91.91%. That is a compound annual growth rate of -63.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 45.55M | -25.11% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 48.08M |
| Impact BioMedical | 47.44M |
| Radiopharm Theranostics | 47.20M |
| Edesa Biotech | 46.68M |
| aTyr Pharma | 46.41M |
| BeyondSpring | 46.05M |
| Mereo BioPharma Group | 45.94M |
| Veraxa Biotech AG | 45.39M |